KROS
Keros Therapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +4.9% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | -2 | 12.51M | $133.89M | +5 | −7 |
| Q1 2026 | 72 | +4 | 12.53M | $138.59M | +8 | −4 |
| Q4 2025 | 68 | +1 | 14.80M | $301.38M | +1 | — |
| Q3 2025 | 16 | 0 | 12.05M | $190.67M | — | — |
| Q2 2025 | 13 | +1 | 9.42M | $125.76M | +2 | −1 |
| Q1 2025 | 9 | -1 | 3.92M | $39.99M | +1 | −2 |
| Q4 2024 | 10 | 0 | 4.67M | $74.00M | +1 | −1 |
| Q3 2024 | 9 | -1 | 4.72M | $274.14M | +1 | −2 |
| Q2 2024 | 10 | — | 3.52M | $160.87M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passief) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passief) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passief) | 2.72M | +3.3% | $43.01M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 2.72M | -0.6% | $42.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 1.33M | +2.6% | $21.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Goldman Sachs Group ✦ | 1.33M | — | $20.97M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | State Street Global Advisors ✦ (passief) | 1.30M | -5.9% | $20.61M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passief) | 837.36K | +1.0% | $13.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 837.36K | +1.0% | $13.25M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Morgan Stanley ✦ | 395.10K | — | $6.25M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 343.88K | — | $5.44M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Arrowstreet Capital ✦ | 258.75K | +300.7% | $4.09M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 41 | AQR Capital Management ✦ | 204.35K | +189.2% | $3.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 42 | Citadel Advisors ✦ | 176.14K | +669.2% | $2.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 43 | Citadel Advisors ✦ | 176.14K | +669.2% | $2.79M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 44 | Renaissance Technologies ✦ | 154.70K | +5.5% | $2.45M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 45 | Fidelity (FMR) ✦ | 100.53K | -38.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 46 | Fidelity (FMR) ✦ | 100.53K | -38.8% | $1.59M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 47 | Two Sigma Investments ✦ | 82.52K | +510.3% | $1.31M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 48 | Millennium Management ✦ | 53.35K | +289.2% | $843,934 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 49 | T. Rowe Price ✦ | 49.98K | +3.2% | $791,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Geen nieuwe bijgehouden kopers dit kwartaal. |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 149 houders, 18.56M aandelen, $201.20M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Director · 1.00K aand @ 10.27 · $10,270
Open-market verkopen (S)
Officer · 4.49K aand · $46,151
Director · 551 aand · $5,675
Officer · 3.57K aand · $36,715
Officer · 1.22K aand · $12,595
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie